FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Faiez Zannad

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Joep Perk; Eva Prescott; Zeljko Reiner; Lars Ryden; Martin Scherer; Wilma J M Scholte op Reimer; Mikko Syvanne; W M Monique Verschuren; Christiaan Vrints; David Wood; Jose Luis Zamorano; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Guy De Backer; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germanò; Helmut Gohlke; Ian Graham; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Faiez Zannad
[European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)].
Mihai Gheorghiade; Claudio Gimpelewicz; Stephen J Greene; Tsushung A Hua; Xavier Jaumont; Anastasia Lesogor; Eldrin F Lewis; Aldo P Maggioni; Scott D Solomon; Faiez Zannad; Fabio Baschiera; Michael Böhm; Jaco Botha; Gregg C Fonarow
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
Valérie Nivet-Antoine; Sophie Visvikis-Siest; Faiez Zannad; Jean-Louis Beaudeux; Charles-Henry COTTART; Xavier Dulcire; Said El Shamieh; carlos labat; ATHANASE BENETOS
Relationship between catalase haplotype and arterial aging.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Faiez Zannad (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Joep Perk; Eva Prescott; Zeljko Reiner; Lars Ryden; Martin Scherer; Wilma J M Scholte op Reimer; Mikko Syvanne; W M Monique Verschuren; Christiaan Vrints; David Wood; Jose Luis Zamorano; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Guy De Backer; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germanò; Helmut Gohlke; Ian Graham; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Faiez Zannad
[European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)].
Giornale italiano di cardiologia (2006) 2013;14(5):328-92.
2013: Mihai Gheorghiade; Claudio Gimpelewicz; Stephen J Greene; Tsushung A Hua; Xavier Jaumont; Anastasia Lesogor; Eldrin F Lewis; Aldo P Maggioni; Scott D Solomon; Faiez Zannad; Fabio Baschiera; Michael Böhm; Jaco Botha; Gregg C Fonarow
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
JAMA : the journal of the American Medical Association 2013;309(11):1125-35.
2013: Valérie Nivet-Antoine; Sophie Visvikis-Siest; Faiez Zannad; Jean-Louis Beaudeux; Charles-Henry COTTART; Xavier Dulcire; Said El Shamieh; carlos labat; ATHANASE BENETOS
Relationship between catalase haplotype and arterial aging.
Atherosclerosis 2013;227(1):100-5.
2013: Andrew P Ambrosy; John C Burnett; Thomas Cook; Gregg C Fonarow; Mihai Gheorghiade; Liliana Grinfeld; Sadiya Khan; Marvin A Konstam; Aldo P Maggioni; Peter S Pang; Karl Swedberg; Brian Traver; James E Udelson; Faiez Zannad
Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial.
European heart journal 2013;34(11):835-43.
2013: Javed Butler; Gregg C Fonarow; Mihai Gheorghiade; Marvin A Konstam; Aldo Maggioni; Robert J Mentz; Haris Subacius; Karl Swedberg; Muthiah Vaduganathan; Faiez Zannad; Andrew P Ambrosy
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial.
Journal of the American College of Cardiology 2013;61(5):571-9.
2013: Romain Pirracchio; Matthieu Resche Rigon; Faiez Zannad; Francois Alla; Alexandre Mebazaa; Sylvie Chevret
Continuous positive airway pressure (CPAP) may not reduce short-term mortality in cardiogenic pulmonary edema: a propensity-based analysis.
Journal of cardiac failure 2013;19(2):108-16.
2013: Satyam Sarma; Haris Subacius; Karl Swedberg; Faiez Zannad; Robert O Bonow; Angela J Fought; Mihai Gheorghiade; Mark Huffman; Marvin Konstam; Mary J Kwasny; Aldo P Maggioni; Robert J Mentz; Savina Nodari
Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.
European journal of heart failure 2013;15(2):194-202.
2013: Daniela Dobre; Henry Krum; Zohra Lamiral; Jan Murin; Alexander Parkhomenko; Bertram Pitt; Patrick Rossignol; Dirk J van Veldhuisen; Faiez Zannad
Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial.
European journal of heart failure 2013;15(2):221-7.
2013: Andreas Schneider; Markus P Schneider; Faiez Zannad; Bengt C Fellstroem; Hallvard Holdaas; Ingar Holme; Alan G Jardine; Roland E Schmieder
Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study.
American journal of nephrology 2013;37(2):144-51.
2013: David E Lanfear; Aldo P Maggioni; Hani N Sabbah; Karl Swedberg; Clyde W Yancy; Faiez Zannad; Andrew P Ambrosy; Angela J Fought; Mihai Gheorghiade; Steven R Goldsmith; Stephen J Greene; Marvin A Konstam; Mary J Kwasny
Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
Circulation. Heart failure 2013;6(1):47-52.
2013: Natalia López-Andrés; Faiez Zannad; ATHANASE BENETOS; Laurent Calvier; Javier Díez; Renaud Fay; carlos labat; Patrick Lacolley; Patrick Rossignol
Absence of cardiotrophin 1 is associated with decreased age-dependent arterial stiffness and increased longevity in mice.
Hypertension 2013;61(1):120-9.
2013: Patrick Rossignol; Michèle Kessler; Faiez Zannad
Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases.
Current opinion in nephrology and hypertension 2013;22(1):59-64.
2013: Laurent Calvier; Rudolf A de Boer; Patrick Lacolley; Ernesto Martinez-Martinez; Maria Miana; Françoise Poirier; Pascal Reboul; Patrick Rossignol; Faiez Zannad; Victoria Cachofeiro; Natalia López-Andrés
Galectin-3 mediates aldosterone-induced vascular fibrosis.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(1):67-75.
2013: Robert J Mentz; Christopher M O'Connor; Karl Swedberg; James E Udelson; Muthiah Vaduganathan; Faiez Zannad; Bradley D Allen; Andrew P Ambrosy; Robert O Bonow; Angela J Fought; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni; Mihai Gheorghiade
Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial.
European journal of heart failure 2013;15(1):61-8.
2012: Ami N Shah; Karl Swedberg; Faiez Zannad; Angela J Fought; Mihai Gheorghiade; Mary J Kwasny; Aldo P Maggioni; Robert J Mentz; Marvin A Konstam
Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial).
The American journal of cardiology 2012;110(12):1803-8.
2012: Faiez Zannad; Jean Dallongeville; Guy De Backer; Ian Graham; Wolfgang Koenig; Matthias Lorenz; Robert J Macfadyen; Giuseppe Mancia; David A Morrow; Zeljko Reiner; Luis M Ruilope; Lars Wilhelmsen
Prevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy.
European journal of preventive cardiology 2012;19(6):1454-64.
2012: Robert J Mentz; Christopher M O'Connor; Peter S Pang; Karl Swedberg; Muthiah Vaduganathan; Faiez Zannad; Andrew P Ambrosy; Matthew J Chung; Mihai Gheorghiade; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni
Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
American heart journal 2012;164(6):884-92.e2.
2012: Michael S Kiernan; Michel Komajda; Kenneth Dickstein; Gary Francis; Felipe A Martinez; James D Neaton; Deborah Wentworth; Faiez Zannad; Marvin A Konstam
Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial.
European journal of heart failure 2012;14(12):1401-9.
2012: Joep Perk; Eva Prescott; Zeljko Reiner; Lars Ryden; Martin Scherer; Mikko Syvänne; W M Monique Verschuren; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Guy De Backer; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Helmut Gohlke; Ian Graham; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Wilma J M Scholte Op Reimer
European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
International journal of behavioral medicine 2012;19(4):403-88.
2012: Stephen J Greene; Matthew E Harinstein; Marvin A Konstam; Aldo P Maggioni; Haris Subačius; Karl Swedberg; Muthiah Vaduganathan; Faiez Zannad; Javed Butler; Mihai Gheorghiade
Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
The American journal of cardiology 2012;110(11):1657-62.
2012: Orly Vardeny; Dong Hong Wu; Faiez Zannad; Akshay Desai; Bertram Pitt; Patrick Rossignol; Scott D Solomon
Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).
Journal of the American College of Cardiology 2012;60(20):2082-9.
2012: Jennifer K Rogers; Harry Shi; Karl Swedberg; Dirk J van Veldhuisen; John Vincent; Faiez Zannad; Henry Krum; John J V McMurray; Stuart J Pocock; Bertram Pitt
Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations.
Circulation 2012;126(19):2317-23.
2012: Muthiah Vaduganathan; Faiez Zannad; Andrew P Ambrosy; Javed Butler; Mihai Gheorghiade; Stephen J Greene; Marvin A Konstam; Aldo P Maggioni; Robert J Mentz; Savina Nodari; Haris P Subacius; Karl Swedberg
Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
Circulation. Heart failure 2012;5(6):750-8.
2012: Faiez Zannad; George L Bakris; Johann Bauersachs; Farzin Beygui; Alain Cohen-Solal; Gerasimos S Filippatos; Wendy Gattis-Stough; Mihai Gheorghiade; Aldo P Maggioni; Ziad A Massy; John J V McMurray; Robert J Mentz; Christopher M O'Connor; Atul Pathak; Ileana L Piña; Patrick Rossignol; Luis M Ruilope; Hani N Sabbah; Domenic A Sica; Allan D Struthers; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Bertram Pitt
Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.
European heart journal 2012;33(22):2782-95.
2012: Robert J Mentz; Angeles Alonso-Garcia; Gheorghe-Andrei Dan; Mona Fiuzat; Sidney Goldstein; Juan-Carlos Kaski; Felipe A Martinez; Bertram Pitt; Luis M Ruilope; Norman Stockbridge; Faiez Zannad; Christopher M O'Connor
Implications of geographical variation on clinical outcomes of cardiovascular trials.
American heart journal 2012;164(3):303-12.
2012: Wolfgang Koenig; Faiez Zannad
Conclusion.
European journal of preventive cardiology 2012;19(2 Suppl):54-5.
2012: Faiez Zannad; Wolfgang Koenig
Risk-guided therapy: a first step to personalized medicine.
European journal of preventive cardiology 2012;19(2 Suppl):5-6.
2012: Patrick Rossignol; Joelle Cridlig; Michèle Kessler; Philippe Lehert; Faiez Zannad
Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.
Hypertension 2012;60(2):339-46.
2012: Natalia López-Andrés; Amélie Rousseau; Faiez Zannad; Xuegen Zhao; Riaz Akhtar; Laurent Calvier; Kennedy Cruickshank; Javier Díez; C Iñigo; carlos labat; Patrick Lacolley; Patrick Rossignol
Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction.
Hypertension 2012;60(2):563-73.
2012: David Preiss; Naveed Sattar; Harry Shi; Karl Swedberg; Dirk J van Veldhuisen; John Vincent; Faiez Zannad; Henry Krum; Bertram Pitt; Stuart J Pocock; John J V McMurray
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
European journal of heart failure 2012;14(8):909-15.
2012: Robert J Mentz; Christopher M O'Connor; Philip H Schmidt; Karl Swedberg; Faiez Zannad; Andrew P Ambrosy; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni; Mihai Gheorghiade
The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial.
Journal of cardiac failure 2012;18(7):515-23.
2012: Joep Perk; Eva Prescott; Zeljko Reiner; Lars Ryden; Martin Scherer; Wilma J M Scholte op Reimer; Mikko Syvänne; W M Monique Verschuren; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Guy De Backer; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Helmut Gohlke; Ian Graham; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
Atherosclerosis 2012;223(1):1-68.
2012: Muthiah Vaduganathan; Faiez Zannad; Christopher Zimmer; John Blair; John C Burnett; Mihai Gheorghiade; Liliana Grinfeld; Marvin A Konstam; Holly B Krasa; Aldo P Maggioni; John Ouyang; Peter S Pang; Karl Swedberg
Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
Journal of cardiovascular medicine (Hagerstown, Md.) 2012;13(7):415-22.
2012: Christian Ukena; Michael Böhm; Daniela Dobre; Ingrid Kindermann; Zohra Lamiral; Felix Mahfoud; Bertram Pitt; Patrick Rossignol; Stephane Tala; Eva Turgonyi; Faiez Zannad
Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS.
Journal of cardiac failure 2012;18(6):439-45.
2012: Bertram Pitt; Piotr Ponikowski; Gerasimos Filippatos; Mihai Gheorghiade; So-Young Kim; Lars Kober; Peter Kolkhof; Henry Krum; Christina Nowack; Faiez Zannad
Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease.
European journal of heart failure 2012;14(6):668-75.
2012: Karl Swedberg; Dirk J van Veldhuisen; John Vincent; Faiez Zannad; Henry Krum; John J V McMurray; Bertram Pitt; Harry Shi
Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study.
Journal of the American College of Cardiology 2012;59(18):1598-603.
2012: Celine Latouche; Natalia López Andrés; Smail Messaoudi; Claudine Perret; Patrick Rossignol; Faiez Zannad; Aurélie Nguyen Dinh Cat; Diego Alvarez de la Rosa; Soumaya El Moghrabi; Nicolette Farman; Ivan Hernandez-Diaz; Frederic Jaisser
Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system.
Hypertension 2012;59(5):966-72.
2012: Faiez Zannad; Stuart J Pocock; Peter Sleight; Wendy Gattis Stough; Hans Wedel; Eric Abadie; Angeles Alonso-Garcia; John G F Cleland; William C Cushman; Nancy L Geller; Eva Lonn; John J V McMurray; Bertram Pitt
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?
European heart journal 2012;33(9):1049-57.
2012: Mihai Gheorghiade; Liliana Grinfeld; Marvin Konstam; Gloria Lan; Aldo Maggioni; Peter S Pang; Philip Schmidt; Karl Swedberg; Brian Traver; James Udelson; Andrew P Ambrosy; John Burnett; Thomas Cook; Gerasimos Filippatos; Faiez Zannad
A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.
Heart failure reviews 2012;17(3):485-509.
2012: Faiez Zannad; Jean Dallongeville; Guy De Backer; Ian Graham; Wolfgang Koenig; Matthias Lorenz; Robert J Macfadyen; Giuseppe Mancia; David A Morrow; Zeljko Reiner; Luis M Ruilope; Lars Wilhelmsen
Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques.
Fundamental & clinical pharmacology 2012;26(2):163-74.
2012: Faiez Zannad; Willem J Remme; Jeffrey S Borer; Wendy Gattis-Stough; Nancy L Geller; John J V McMurray; Bertram Pitt; Stuart J Pocock
When to stop a clinical trial early for benefit: lessons learned and future approaches.
Circulation. Heart failure 2012;5(2):294-302.
2012: Andrew P Ambrosy; Angela J Fought; Mihai Gheorghiade; Mark D Huffman; Sadiya Khan; Marvin A Konstam; Mary J Kwasny; Aldo P Maggioni; Karl Swedberg; Muthiah Vaduganathan; Faiez Zannad
Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial.
European journal of heart failure 2012;14(3):302-11.
2012: Steven J Keteyian; Dalane Kitzman; Joel Landzberg; Faiez Zannad; J Malcolm Arnold; Daniel R Bensimhon; Clinton A Brawner; Peter Brubaker; Anne S Hellkamp; Greg Ewald
Predicting maximal HR in heart failure patients on β-blockade therapy.
Medicine and science in sports and exercise 2012;44(3):371-6.
2012: Daniela Dobre; Marco Metra; Patrick Rossignol; Faiez Zannad
Can we prevent or treat renal dysfunction in chronic heart failure?
Heart failure reviews 2012;17(2):283-90.
2012: Patrick Rossignol; Stéphane Tala; Sunil Bhandari; John G F Cleland; Daniela Dobre; Renaud Fay; Finn Gustafsson; Zohra Lamiral; Bertram Pitt; Faiez Zannad
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study.
Circulation 2012;125(2):271-9.
2012: Bertram Pitt; Faiez Zannad
Eplerenone: is it time to add this drug to current heart failure therapy?
Therapeutic advances in chronic disease 2012;3(1):5-9.
2012: Bertram Pitt; Faiez Zannad
The detection of myocardial fibrosis: an opportunity to reduce cardiovascular risk in patients with diabetes mellitus?
Circulation. Cardiovascular imaging 2012;5(1):9-11.
2012: Ulf Neisius; Josep Redon; Enrico Agabiti Rosei; Patrick Rossignol; Markus P Schneider; Jan A Staessen; Katarzyna Stolarz-Skrzypek; Chiara Taurino; Alberto Zanchetti; Faiez Zannad; Anna F Dominiczak; Kalina Kawecka-Jaszcz; Łukasz Klima; Tatiana Kuznetsova; Stéphane Laurent; Laura Lonati; Fernando Martinez; John D McClure; Olle Melander; Maria L Muiesan; Grzegorz Bilo; Cedric Collin; Christian Delles
Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes.
Journal of hypertension 2012;30(1):67-74.
2012: Christopher M O'Connor; Ileana L Piña; David Rendall; David Whellan; Daniel Wojdyla; Faiez Zannad; Eric Leifer; Robert M Clare; Lawton S Cooper; Stephen J Ellis; Lawrence J Fine; Mona Fiuzat; Jerome L Fleg; Steven J Keteyian; Dalane W Kitzman; William E Kraus; Kerry L Lee
Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.
Circulation. Heart failure 2012;5(1):63-71.
2012: G Michael Felker; Mona Fiuzat; Dalane W Kitzman; Ileana L Piña; Linda K Shaw; Shailesh C Shirolkar; David Whellan; Faiez Zannad; Luca Bettari; Robert Clare; Mark Donahue; Christopher M O'Connor
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study.
Circulation. Heart failure 2012;5(1):72-8.
2011: Theresa A McDonagh; Marco Metra; Faiez Zannad; Mihai Gheorghiade; Michel Komajda; Aldo P Maggioni; Henry J Dargie
Clinical trials in acute heart failure: simpler solutions to complex problems. Consensus document arising from a European Society of Cardiology cardiovascular round-table think tank on acute heart failure, 12 May 2009.
European journal of heart failure 2011;13(12):1253-60.
2011: Natalia López-Andrés; Beatriz Martin-Fernandez; Patrick Rossignol; Faiez Zannad; Victoria Cachofeiro; Maria Antonia Fortuno; Vicente Lahera; Javier Díez
A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.
American journal of physiology. Heart and circulatory physiology 2011;301(6):H2372-82.
2011: Patrick Rossignol; Renaud Fay; Finn Gustafsson; Joël Ménard; Bertram Pitt; Faiez Zannad
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
Journal of the American College of Cardiology 2011;58(19):1958-66.
2011: Jean-Marc Boivin; Daniela Dobre; Renaud Fay; Patrick Rossignol; Tzu-Jen Tsou-Gaillet; Faiez Zannad
Influence of the recommendations on the implementation of home blood pressure measurement by French general practitioners: a 2004-2009 longitudinal survey.
Journal of hypertension 2011;29(11):2105-15.
2011: Michael Böhm; Peter Bramlage; Jean-Marie Ketelslegers; Stephan H Schirmer; Eva Turgonyi; Adriaan A Voors; Faiez Zannad
Biomarkers: optimizing treatment guidance in heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(11):973-81.
2011: William B White; Craig Wilson; George L Bakris; Richard M Bergenstal; Christopher P Cannon; William C Cushman; Penny Fleck; Simon Heller; Cyrus Mehta; Steven E Nissen; Alfonso Perez; Faiez Zannad
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.
American heart journal 2011;162(4):620-626.e1.
2011: John E A Blair; John C Burnett; Umberto Campia; Thomas Cook; Mihai Gheorghiade; Liliana Grinfeld; Marvin A Konstam; Aldo P Maggioni; Marco Metra; Peter S Pang; Robert W Schrier; Karl Swedberg; Brian Traver; James E Udelson; Faiez Zannad; Andrew Ambrosy
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.
European heart journal 2011;32(20):2563-72.
2011: Santo Dellegrottaglie; George Eisele; Frederic Finkelstein; Brenda W Gillespie; Gowrishankar Gnanasekaran; Alan L Hinderliter; Margaret Kiser; Nathan W Levin; Robin L Sands; Rajiv Saran; David Sengstock; Faiez Zannad; Valerie Cattan; Sanjay Rajagopalan
Association between markers of collagen turnover, arterial stiffness and left ventricular hypertrophy in chronic kidney disease (CKD): the Renal Research Institute (RRI)-CKD study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2011;26(9):2891-8.
2011: Cord Manhenke; Stein Orn; Anca Radauceanu; Iain Squire; Faiez Zannad; François Alla; Kenneth Dickstein
The prognostic value of circulating markers of collagen turnover after acute myocardial infarction.
International journal of cardiology 2011;150(3):277-82.
2011: Michael Domanski; Nancy Geller; Stuart Pocock; James Revkin; Corine Bernaud; Jeffrey Borer; Faiez Zannad
Surrogate endpoints in randomized cardiovascular clinical trials.
Fundamental & clinical pharmacology 2011;25(4):411-3.
2011: Larry A Allen; Paul S Chan; Shannon M Dunlay; Mihai Gheorghiade; Paul J Hauptman; Marvin A Konstam; Kimberly J Reid; Faiez Zannad; John A Spertus
Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life.
Circulation. Cardiovascular quality and outcomes 2011;4(4):389-98.
2011: Hallvard Holdaas; Ingar Holme; Alan G Jardine; Gudrun E Norby; Roland E Schmieder; Faiez Zannad; Bengt C Fellström
Rosuvastatin in diabetic hemodialysis patients.
Journal of the American Society of Nephrology : JASN 2011;22(7):1335-41.
2011: Peter S Pang; Mihai Gheorghiade; Jamil Dihu; Karl Swedberg; Sadiya Khan; Aldo P Maggioni; Liliana Grinfeld; Faiez Zannad; John C Burnett; John Ouyang; James E Udelson; Marvin A Konstam
Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials.
American heart journal 2011;161(6):1067-72.
2011: Bertram Pitt; Stefan D Anker; David A Bushinsky; Dalane W Kitzman; Faiez Zannad; I-Zu Huang
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial.
European heart journal 2011;32(7):820-8.
2011: Siobhan Gallanagh; Davide Castagno; Ben Wilson; Erland Erdmann; Faiez Zannad; Willem J Remme; José L Lopez-Sendon; Philippe Lechat; Ferenc Follath; Christer Höglund; Viacheslav Mareev; Zygmunt Sadowski; Ricardo J Seabra-Gomes; Henry J Dargie; John J V McMurray
Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II).
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2011;25(1):77-85.
2011: Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Eplerenone in patients with systolic heart failure and mild symptoms.
The New England journal of medicine 2011;364(1):11-21.
2011: Thomas Eschenhagen; Thomas Force; Michael S Ewer; Gilles W De Keulenaer; Thomas M Suter; Stefan D Anker; Metin Avkiran; Evandro de Azambuja; Jean-Luc Balligand; Dirk L Brutsaert; Gianluigi Condorelli; Arne Hansen; Stephane Heymans; Joseph A Hill; Emilio Hirsch; Denise Hilfiker-Kleiner; Stefan Janssens; Steven de Jong; Gitte Neubauer; Burkert Pieske; Piotr Ponikowski; Munir Pirmohamed; Mathias Rauchhaus; Douglas Sawyer; Peter H Sugden; Johann Wojta; Faiez Zannad; Ajay M Shah
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.
European journal of heart failure 2011;13(1):1-10.
2011: Mihai Gheorghiade; Mazen Albaghdadi; Faiez Zannad; Gregg C Fonarow; Michael Böhm; Claudio Gimpelewicz; Jaco Botha; Shelley Moores; Eldrin F Lewis; Henning Rattunde; Aldo Maggioni
Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT).
European journal of heart failure 2011;13(1):100-6.
2010: Ghassan Watfa; Patrick Rossignol; Anna Kearney-Schwartz; Renaud Fay; Serge Bracard; Jacques Felblinger; Jean-Marc Boivin; Patrick Lacolley; Faiez Zannad; ATHANASE BENETOS
Use of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaints.
Journal of hypertension 2010;28(12):2485-93.
2010: Farzin Beygui; Eric Vicaut; Patrick Ecollan; Jacques Machecourt; Eric Van Belle; Faiez Zannad; Gilles Montalescot
Rationale for an early aldosterone blockade in acute myocardial infarction and design of the ALBATROSS trial.
American heart journal 2010;160(4):642-8.
2010: Keld Kjeldsen; Dan Atar; Jonas Hallén; Panos Vardas; Faiez Zannad; Stig Haunsø
Sudden cardiac death--the challenge to cardiology.
Fundamental & clinical pharmacology 2010;24(5):535-7.
2010: Aldo P Maggioni; Ulf Dahlström; Gerasimos Filippatos; Ovidiu Chioncel; Marisa Crespo Leiro; Jaroslaw Drozdz; Friedrich Fruhwald; Lars Gullestad; Damien Logeart; Marco Metra; John Parissis; Hans Persson; Piotr Ponikowski; Mathias Rauchhaus; Adriaan Voors; Olav Wendelboe Nielsen; Faiez Zannad; Luigi Tavazzi
EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).
European journal of heart failure 2010;12(10):1076-84.
2010: Bertram Pitt; Faiez Zannad; Mihai Gheorghiade; Felipe Martínez; Thomas E Love; Casey Daniel; Ali Ahmed
Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial.
International journal of cardiology 2010;143(3):309-16.
2010: Ulf Dahlström; Gerasimos Filippatos; Aldo Maggioni; Luigi Tavazzi; Faiez Zannad
Heart Failure Pilot protocol.
European heart journal 2010;31(18):2184-6.
2010: Franz H Messerli; Jan A Staessen; Faiez Zannad
Of fads, fashion, surrogate endpoints and dual RAS blockade.
European heart journal 2010;31(18):2205-8.
2010: Pascal Bilbault; Chantal Belorgey; Faiez Zannad; Danielle Golinelli; Yannick Pletan
Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011.
Thérapie 2010;65(4):301-8, 291-9.
2010: Norman C Wang; Jonathan P Piccini; Marvin A Konstam; Aldo P Maggioni; Brian Traver; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; Christopher M O'Connor; Alan B Miller; Liliana Grinfeld; Mihai Gheorghiade
Implantable cardioverter-defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction.
American journal of therapeutics 2010;17(4):e78-87.
2010: Faiez Zannad; Patrick Rossignol; Wafae Iraqi
Extracellular matrix fibrotic markers in heart failure.
Heart failure reviews 2010;15(4):319-29.
2010: Finn Gustafsson; Dan Atar; Bertram Pitt; Faiez Zannad; Marc A Pfeffer
Maximizing scientific knowledge from randomized clinical trials.
American heart journal 2010;159(6):937-43.
2010: Faiez Zannad; John J V McMurray; Helmut Drexler; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Bertram Pitt
Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).
European journal of heart failure 2010;12(6):617-22.
2010: Davide Castagno; Pardeep S Jhund; John J V McMurray; James D Lewsey; Erland Erdmann; Faiez Zannad; Willem J Remme; José L Lopez-Sendon; Philippe Lechat; Ferenc Follath; Christer Höglund; Viacheslav Mareev; Zygmunt Sadowski; Ricardo J Seabra-Gomes; Henry J Dargie
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial.
European journal of heart failure 2010;12(6):607-16.
2010: Natalia Lopez-Andres; Maria A Fortuno; Javier Diez; Faiez Zannad; Patrick Lacolley; Patrick Rossignol
Vascular effects of cardiotrophin-1: a role in hypertension?
Journal of hypertension 2010;28(6):1261-72.
2010: Mihai Gheorghiade; Ferenc Follath; Piotr Ponikowski; Jeffrey H Barsuk; John E A Blair; John G Cleland; Kenneth Dickstein; Mark H Drazner; Gregg C Fonarow; Tiny Jaarsma; Guillaume Jondeau; Jose Lopez Sendon; Alexander Mebazaa; Marco Metra; Markku Nieminen; Peter S Pang; Petar Seferovic; Lynne W Stevenson; Dirk J van Veldhuisen; Faiez Zannad; Stefan D Anker; Andrew Rhodes; John J V McMurray; Gerasimos Filippatos
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine.
European journal of heart failure 2010;12(5):423-33.
2010: Shannon M Dunlay; Mihai Gheorghiade; Kimberly J Reid; Larry A Allen; Paul S Chan; Paul J Hauptman; Faiez Zannad; Aldo P Maggioni; Karl Swedberg; Marvin A Konstam; John A Spertus
Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial.
European journal of heart failure 2010;12(4):367-74.
2010: Alexandra Rousseau; Annie Robert; Grigoris Gerotziafas; Dahlia Torchin; Faiez Zannad; Karine Lacut; Christian Libersa; Eric Dasque; Jean-Louis Démolis; Ismail Elalamy; Tabassome Simon
Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double-blind placebo-controlled study.
Fundamental & clinical pharmacology 2010;24(2):239-45.
2010: G Michael Felker; Peter S Pang; Kirkwood F Adams; John G F Cleland; Gad Cotter; Kenneth Dickstein; Gerasimos S Filippatos; Gregg C Fonarow; Barry H Greenberg; Adrian F Hernandez; Sadiya Khan; Michel Komajda; Marvin A Konstam; Peter P Liu; Aldo P Maggioni; Barry M Massie; John J McMurray; Mandeep R Mehra; Marco Metra; John O'Connell; Christopher M O'Connor; Ileana L Pina; Piotr Ponikowski; Hani N Sabbah; John R Teerlink; James E Udelson; Clyde W Yancy; Faiez Zannad; Mihai Gheorghiade
Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.
Circulation. Heart failure 2010;3(2):314-25.
2010: Etienne Huvelle; Renaud Fay; francois alla; Alain Cohen Solal; Alexandre Mebazaa; Faiez Zannad
Left bundle branch block and mortality in patients with acute heart failure syndrome: a substudy of the EFICA cohort.
European journal of heart failure 2010;12(2):156-63.
2010: Ala'a Alkerwi; Michèle Guillaume; Faiez Zannad; Ulrich Laufs; Marie-Lise Lair
Nutrition, environment and cardiovascular health (NESCAV): protocol of an inter-regional cross-sectional study.
BMC public health 2010;10():698.
2009: Chris Adamopoulos; Ali Ahmed; Renaud Fay; Michael Angioi; Gerasimos Filippatos; John Vincent; Bertram Pitt; Faiez Zannad
Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial.
European journal of heart failure 2009;11(11):1099-105.
2009: Faiez Zannad; Nelly Agrinier; francois alla
Heart failure burden and therapy.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11 Suppl 5():v1-9.
2009: G Michael Felker; David Whellan; William E Kraus; Robert Clare; Faiez Zannad; Mark P Donahue; Kirkwood F Adams; Robert McKelvie; Ileana L Piña; Christopher M O'Connor
N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study.
American heart journal 2009;158(4 Suppl):S37-44.
2009: Faiez Zannad; Bertram Pitt
Biomarkers of extracellular matrix turnover.
Heart failure clinics 2009;5(4):589-99.
2009: Peter S Pang; Marvin A Konstam; Holly B Krasa; Karl Swedberg; Faiez Zannad; John E A Blair; Christopher Zimmer; John R Teerlink; Aldo P Maggioni; John C Burnett; Liliana Grinfeld; John Ouyang; James E Udelson; Mihai Gheorghiade
Effects of tolvaptan on dyspnoea relief from the EVEREST trials.
European heart journal 2009;30(18):2233-40.
2009: Chris Adamopoulos; Bertram Pitt; Xuemei Sui; Thomas E Love; Faiez Zannad; Ali Ahmed
Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study.
International journal of cardiology 2009;136(3):270-7.
2009: Laure Joly; Christine Perret-Guillaume; Anna Kearney-Schwartz; Paolo Salvi; Damien Mandry; Pierre-Yves Marie; Gilles Karcher; Patrick Rossignol; Faiez Zannad; ATHANASE BENETOS
Pulse wave velocity assessment by external noninvasive devices and phase-contrast magnetic resonance imaging in the obese.
Hypertension 2009;54(2):421-6.
2009: John E A Blair; Sadiya Khan; Marvin A Konstam; Karl Swedberg; Faiez Zannad; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; James E Udelson; Christopher A Zimmer; John Ouyang; Chien-Feng Chen; Mihai Gheorghiade
Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.
European heart journal 2009;30(13):1666-73.
2009: Mihai Gheorghiade; Kirkwood F Adams; John G F Cleland; Gad Cotter; G Michael Felker; Gerasimos Filippatos; Gregg C Fonarow; Barry H Greenberg; Adrian F Hernandez; Sadiya Khan; Michel Komajda; Marvin A Konstam; Peter P Liu; Aldo P Maggioni; Barry M Massie; John J McMurray; Mandeep Mehra; Marco Metra; John O'Connell; Christopher M O'Connor; Peter S Pang; Ileana L Piña; Hani N Sabbah; John R Teerlink; James E Udelson; Clyde W Yancy; Faiez Zannad; Norman Stockbridge
Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
American heart journal 2009;157(6):957-70.
2009: Wafae Iraqi; Patrick Rossignol; Michael Angioi; Renaud Fay; Josette Nuée; Jean-Marie Ketelslegers; John Vincent; Bertram Pitt; Faiez Zannad
Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Circulation 2009;119(18):2471-9.
2009: Christopher M O'Connor; David Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
JAMA : the journal of the American Medical Association 2009;301(14):1439-50.
2009: Bengt C Fellström; Alan G Jardine; Roland E Schmieder; Hallvard Holdaas; Kym Bannister; Jaap Beutler; Dong-Wan Chae; Alejandro Chevaile; Stuart M Cobbe; Carola Grönhagen-Riska; José J De Lima; Robert Lins; Gert Mayer; Alan W McMahon; Hans-Henrik Parving; Giuseppe Remuzzi; Ola Samuelsson; Sandor Sonkodi; D Sci; Gultekin Süleymanlar; Dimitrios Tsakiris; Vladimir Tesar; Vasil Todorov; Andrzej Wiecek; Rudolf P Wüthrich; Mattis Gottlow; Eva Johnsson; Faiez Zannad
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
The New England journal of medicine 2009;360(14):1395-407.
2009: Jay Cohn; John G F Cleland; Jacobus Lubsen; Jeffrey S Borer; Philippe Gabriel STEG; Michael Perelman; Faiez Zannad
Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?
Journal of cardiac failure 2009;15(3):199-205.
2009: Jean-Marc Boivin; Faiez Zannad
[Official recommendations and guidelines for the management and reimbursement of severe hypertension as a chronic disease].
Presse médicale (Paris, France : 1983) 2009;38(4):652-60.
2009: Anna Kearney-Schwartz; Patrick Rossignol; Serge Bracard; Jacques Felblinger; Renaud Fay; Jean-Marc Boivin; Thomas Lecompte; Patrick Lacolley; ATHANASE BENETOS; Faiez Zannad
Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints.
Stroke; a journal of cerebral circulation 2009;40(4):1229-36.
2009: Susanne W M van den Borne; Satoshi Isobe; H Reinier Zandbergen; Peng Li; Artiom Petrov; Nathan D Wong; Shinichiro Fujimoto; Ai Fujimoto; Dagfinn Lovhaug; Jos F M Smits; Mat J A P Daemen; W Matthijs Blankesteijn; Chris P M Reutelingsperger; Faiez Zannad; Navneet Narula; Mani A Vannan; Bertram Pitt; Leo Hofstra; Jagat Narula
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling.
JACC. Cardiovascular imaging 2009;2(2):187-98.
2009: Stephane Heymans; Emilio Hirsch; Stefan D Anker; Pal Aukrust; Jean-Luc Balligand; Jan Willem Cohen-Tervaert; Helmut Drexler; Gerasimos Filippatos; Stephan B Felix; Lars Gullestad; Denise Hilfiker-Kleiner; Stefan Janssens; Roberto Latini; Gitte Neubauer; Walter J Paulus; Burkert Pieske; Piotr Ponikowski; Blanche Schroen; Heinz-Peter Schultheiss; Carsten Tschöpe; Marc van Bilsen; Faiez Zannad; John McMurray; Ajay M Shah
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
European journal of heart failure 2009;11(2):119-29.
2009: Bengt Fellström; Hallvard Holdaas; Alan G Jardine; Maria K Svensson; Mattis Gottlow; Roland E Schmieder; Faiez Zannad
Cardiovascular disease in patients with renal disease: the role of statins.
Current medical research and opinion 2009;25(1):271-85.
2008: Susanne W M van den Borne; Satoshi Isobe; Johan W Verjans; Artiom Petrov; Dagfinn Lovhaug; Peng Li; H Reinier Zandbergen; Youping Ni; Peter Frederik; Jun Zhou; Bente Arbo; Astri Rogstad; Alan Cuthbertson; Salah Chettibi; Chris P M Reutelingsperger; W Matthijs Blankesteijn; Jos F M Smits; Mat J A P Daemen; Faiez Zannad; Mani A Vannan; Navneet Narula; Bertram Pitt; Leo Hofstra; Jagat Narula
Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction.
Journal of the American College of Cardiology 2008;52(24):2017-28.
2008: Karl Swedberg; John G F Cleland; Martin R Cowie; Markku Nieminen; silvia priori; Luigi Tavazzi; Dirk J van Veldhuisen; Luis Alonso-Pulpon; John Camm; Kenneth Dickstein; Helmut Drexler; Gerasimos Filippatos; Cecilia Linde; José Lopez-Sendon; Massimo Santini; Faiez Zannad
Successful treatment of heart failure with devices requires collaboration.
European journal of heart failure 2008;10(12):1229-35.
2008: John E A Blair; Faiez Zannad; Marvin A Konstam; Thomas Cook; Brian Traver; John C Burnett; Liliana Grinfeld; Holly Krasa; Aldo P Maggioni; Cesare Orlandi; Karl Swedberg; James E Udelson; Christopher Zimmer; Mihai Gheorghiade
Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.
Journal of the American College of Cardiology 2008;52(20):1640-8.
2008: George Bakris; Michael Böhm; Gilles Dagenais; Hans-Christoph Diener; Toshiro Fujita; Philip B Gorelick; Sverre Erik Kjeldsen; Markku Laakso; Giuseppe Mancia; Bertram Pitt; Arya Sharma; Peter Sleight; Koon Teo; Thomas Unger; Michael Weber; Bryan Williams; Faiez Zannad
Cardiovascular protection for all individuals at high risk: evidence-based best practice.
Clinical research in cardiology : official journal of the German Cardiac Society 2008;97(10):713-25.
2008: Gaëlle Bello; Frédéric Cailotto; Didier Hanriot; Marie-Nathalie Kolopp-Sarda; Véronique Latger-Cannard; Ketsia Hess; Faiez Zannad; Dan Longrois; Armelle Ropars
C-reactive protein (CRP) increases VEGF-A expression in monocytic cells via a PI3-kinase and ERK 1/2 signaling dependent pathway.
Atherosclerosis 2008;200(2):286-93.
2008: Xuemei Sui; Mihai Gheorghiade; Faiez Zannad; James B Young; Ali Ahmed
A propensity matched study of the association of education and outcomes in chronic heart failure.
International journal of cardiology 2008;129(1):93-9.
2008: Faiez Zannad
Implications of the ADVANCE study for clinical practice.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2008;26(3):S29-32.
2008: Faiez Zannad; Enrico Agabiti-Rosei
Profile of patients with type 2 diabetes in France and Italy.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2008;26(3):S3-6.
2008: Alan S Maisel; Christian Mueller; Kirkwood F Adams; Stefan D Anker; Nadia Aspromonte; John G F Cleland; Alain Cohen-Solal; Ulf Dahlstrom; Anthony DeMaria; Salvatore Di Somma; Gerasimos S Filippatos; Gregg C Fonarow; Patrick Jourdain; Michel Komajda; Peter P Liu; Theresa McDonagh; Kenneth McDonald; Alexandre Mebazaa; Markku S Nieminen; W Frank Peacock; Marco Tubaro; Roberto Valle; Marc Vanderhyden; Clyde W Yancy; Faiez Zannad; Eugene Braunwald
State of the art: using natriuretic peptide levels in clinical practice.
European journal of heart failure 2008;10(9):824-39.
2008: Anca Radauceanu; Camille Ducki; jean-marc virion; Patrick Rossignol; Ziad Mallat; John McMurray; Dirk J van Veldhuisen; Luigi Tavazzi; Douglas L Mann; Josette Capiaumont-Vin; Minjiang Li; Didier Hanriot; Faiez Zannad
Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure.
Journal of cardiac failure 2008;14(6):467-74.
2008: Bertram Pitt; Ali Ahmed; Thomas E Love; Henry Krum; Jose Nicolau; José S Cardoso; Alexander Parkhomenko; Michael Aschermann; Ramon Corbalán; Henry Solomon; Harry Shi; Faiez Zannad
History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure.
Hypertension 2008;52(2):271-8.
2008: Willem J Remme; John J V McMurray; F D Richard Hobbs; Alain Cohen-Solal; Jose Lopez-Sendon; Alessandro Boccanelli; Faiez Zannad; Bernhard Rauch; Karen Keukelaar; Cezar Macarie; Witold Ruzyllo; Charles Cline
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians.
European heart journal 2008;29(14):1739-52.
2008: Norman C Wang; Aldo P Maggioni; Marvin A Konstam; Faiez Zannad; Holly B Krasa; John C Burnett; Liliana Grinfeld; Karl Swedberg; James E Udelson; Thomas Cook; Brian Traver; Christopher Zimmer; Cesare Orlandi; Mihai Gheorghiade
Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction.
JAMA : the journal of the American Medical Association 2008;299(22):2656-66.
2008: Ahmed Zaiem; Faiez Zannad
Perindopril: beyond lowering blood pressure.
Future cardiology 2008;4(3):219-35.
2008: Ali Ahmed; Richard M Allman; Gregg C Fonarow; Thomas E Love; Faiez Zannad; Louis J Dell'Italia; Michel White; Mihai Gheorghiade
Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study.
Journal of cardiac failure 2008;14(3):211-8.
2008: Didier Quilliot; Philip Böhme; Faiez Zannad; Olivier Ziegler
Sympathetic-leptin relationship in obesity: effect of weight loss.
Metabolism: clinical and experimental 2008;57(4):555-62.
2008: Didier Hanriot; Gaëlle Bello; Armelle Ropars; Carole Seguin-Devaux; Gaël Poitevin; Sandrine Grosjean; Véronique Latger-Cannard; Yvan Devaux; Faiez Zannad; Véronique Regnault; Patrick Lacolley; Paul-Michel Mertes; Ketsia Hess; Dan Longrois
C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes.
Thrombosis and haemostasis 2008;99(3):558-69.
2008: Eldrin F Lewis; Eric J Velazquez; Scott D Solomon; Anne S Hellkamp; John J V McMurray; Jasmine Mathias; Jean-Lucien Rouleau; Aldo P Maggioni; Karl Swedberg; Lars Kober; Harvey White; Anthony J Dalby; Gary S Francis; Faiez Zannad; Robert M Califf; Marc A Pfeffer
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.
European heart journal 2008;29(6):748-56.
2008: Leonardo De Luca; Alexandre Mebazaa; Gerasimos Filippatos; John T Parissis; Michael Böhm; Adriaan A Voors; Markku Nieminen; Faiez Zannad; Andrew Rhodes; Ali El-Banayosy; Kenneth Dickstein; Mihai Gheorghiade
Overview of emerging pharmacologic agents for acute heart failure syndromes.
European journal of heart failure 2008;10(2):201-13.
2008: Faiez Zannad; Wendy Gattis Stough; Bertram Pitt; John G F Cleland; Kirkwood F Adams; Nancy L Geller; Christian Torp-Pedersen; Bridget-Anne Kirwan; Ferenc Follath
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition.
European heart journal 2008;29(3):413-21.
2008: Faiez Zannad; Anne Jakobsen; Jose Heroys; Ann Ralph; Tomas Rees; Michael Shaw
Cardiovascular high-risk patients--treat to protect, but whom?
Medscape journal of medicine 2008;10 Suppl():S2.
2008: Alexandre Mebazaa; Mihai Gheorghiade; Ileana L Piña; Veli-Pekka Harjola; Steven M Hollenberg; Ferenc Follath; Andrew Rhodes; Patrick Plaisance; Edmond Roland; Markku Nieminen; Michel Komajda; Alexander Parkhomenko; Josep Masip; Faiez Zannad; Gerasimos Filippatos
Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes.
Critical care medicine 2008;36(1 Suppl):S129-39.
2008: Richard M Lewis; David J Gordon; Philip A Poole-Wilson; Jeffrey S Borer; Faiez Zannad
Similarities and differences in design considerations for cell therapy and pharmacologic cardiovascular clinical trials.
Cardiology 2008;110(2):73-80.
2007: Michèle Kessler; Faiez Zannad; Philippe Lehert; Jean-Pierre Grünfeld; Christian Thuilliez; Alain Leizorovicz; Philippe Lechat
Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(12):3573-9.
2007: Joël Constans; Christine Germain; Philippe Gosse; Jacques Taillard; Kiet Phong TIEV; Isabelle Delevaux; Luc Mouthon; Claude Schmidt; Florence Granel; Pascale Soria; François Lifermann; Gabriel Etienne; Fabrice Bonnet; Karim Zoulim; Dominique Farge-Bancel; Isabelle Marie; Yannick Allanore; jean paul cabane; Alain Amonchot; Isabelle Macquin-Mavier; Marianne Saves; Faiez Zannad; Claude Conri
Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study.
Journal of hypertension 2007;25(9):1900-6.
2007: Chris Adamopoulos; Faiez Zannad; Renaud Fay; Alexandre Mebazaa; Alain Cohen-Solal; Louis Guize; Yves Juillière; francois alla
Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failure.
European journal of heart failure 2007;9(9):935-41.
2007: Hugues Blangy; Nicolas Sadoul; Brigitte Dousset; Anca Radauceanu; Renaud Fay; Etienne Aliot; Faiez Zannad
Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2007;9(9):724-9.
2007: Wendy Gattis Stough; Faiez Zannad; Bertram Pitt; Sidney Goldstein
Globalization of cardiovascular clinical research: the balance between meeting medical needs and maintaining scientific standards.
American heart journal 2007;154(2):232-8.
2007: Anna Kearney-Schwartz; jean-marc virion; Jean-François Stoltz; Pierre Drouin; Faiez Zannad
Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
Fundamental & clinical pharmacology 2007;21(4):387-96.
2007: Jeffrey S Borer; Hubert G Pouleur; Eric Abadie; Ferrenc Follath; Janet Wittes; Marc A Pfeffer; Bertram Pitt; Faiez Zannad
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
European heart journal 2007;28(15):1904-9.
2007: Sanjay Rajagopalan; Faiez Zannad; Anca Radauceanu; Robert Glazer; Yan Jia; Margaret Forney Prescott; Mbabazi Kariisa; Bertram Pitt
Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
The American journal of cardiology 2007;100(2):222-6.
2007: Ali Ahmed; Faiez Zannad; Thomas E Love; Jose A Tallaj; Mihai Gheorghiade; Olaniyi James Ekundayo; Bertram Pitt
A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure.
European heart journal 2007;28(11):1334-43.
2007: Gerasimos Filippatos; Faiez Zannad
An introduction to acute heart failure syndromes: definition and classification.
Heart failure reviews 2007;12(2):87-90.
2007: francois alla; Faiez Zannad; Gerasimos Filippatos
Epidemiology of acute heart failure syndromes.
Heart failure reviews 2007;12(2):91-5.
2007: Faiez Zannad; Renaud Fay
Blood pressure-lowering efficacy of olmesartan relative to other angiotensin II receptor antagonists: an overview of randomized controlled studies.
Fundamental & clinical pharmacology 2007;21(2):181-90.
2007: Faiez Zannad
Aldosterone antagonist therapy in resistant hypertension.
Journal of hypertension 2007;25(4):747-50.
2007: Anca Radauceanu; Frédéric Moulin; Wassila Djaballah; Pierre-Yves Marie; francois alla; Brigitte Dousset; jean-marc virion; Josette Capiaumont; Gilles Karcher; Etienne Aliot; Faiez Zannad
Residual stress ischaemia is associated with blood markers of myocardial structural remodelling.
European journal of heart failure 2007;9(4):370-6.
2007: Mihai Gheorghiade; Marvin A Konstam; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; John Ouyang; Christopher Zimmer; Cesare Orlandi
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.
JAMA : the journal of the American Medical Association 2007;297(12):1332-43.
2007: Marvin A Konstam; Mihai Gheorghiade; John C Burnett; Liliana Grinfeld; Aldo P Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Thomas Cook; John Ouyang; Christopher Zimmer; Cesare Orlandi
Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.
JAMA : the journal of the American Medical Association 2007;297(12):1319-31.
2007: Sheldon Tobe; Kalina Kawecka-Jaszcz; Faiez Zannad; George Vetrovec; Rajiv Patni; Harry Shi
Amlodipine added to quinapril vs quinapril alone for the treatment of hypertension in diabetes: the Amlodipine in Diabetes (ANDI) trial.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(2):120-7.
2007: Bengt Fellström; Hallvard Holdaas; Alan Jardine; Helen Rose; Roland Schmieder; Wim Wilpshaar; Faiez Zannad
Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study.
Kidney & blood pressure research 2007;30(5):314-22.
2007: Faiez Zannad; Etienne Huvelle; Kenneth Dickstein; Dirk J van Veldhuisen; Christoph Stellbrink; Lars Køber; Serge Cazeau; Philippe Ritter; Aldo P Maggioni; Roberto Ferrari; Philippe Lechat
Left bundle branch block as a risk factor for progression to heart failure.
European journal of heart failure 2007;9(1):7-14.
2007: Aldo P Maggioni; Bernadette Darne; Dan Atar; Eric Abadie; Bertram Pitt; Faiez Zannad
FDA and CPMP rulings on subgroup analyses.
Cardiology 2007;107(2):97-102.
2006: Faiez Zannad; Alexandre Mebazaa; Yves Juillière; Alain Cohen-Solal; Louis Guize; francois alla; Pierre Rougé; Patrick Blin; Marie-Hélène Barlet; Laurence Paolozzi; Catherine Vincent; Michel Desnos; Kamran Samii
Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: The EFICA study.
European journal of heart failure 2006;8(7):697-705.
2006: Faiez Zannad; Michèle Kessler; P Lehert; Jean-Pierre Grünfeld; Christian Thuilliez; Alain Leizorovicz; P Lechat
Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
Kidney international 2006;70(7):1318-24.
2006: Lars Køber; Karl Swedberg; john mcmurray; Marc A Pfeffer; Eric J Velazquez; Rafael Diaz; Aldo P Maggioni; Viatcheslav Mareev; Grzegorz Opolski; Frans Van de Werf; Faiez Zannad; Georg Ertl; Scott D Solomon; Steven Zelenkofske; Jean-Lucien Rouleau; Jeffrey D Leimberger; Robert M Califf
Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction.
European journal of heart failure 2006;8(6):591-8.
2006: Peter Sleight; Hubert G Pouleur; Faiez Zannad
Benefits, challenges, and registerability of the polypill.
European heart journal 2006;27(14):1651-6.
2006: Faiez Zannad; Chris Adamopoulos; Alexandre Mebazaa; Mihai Gheorghiade
The challenge of acute decompensated heart failure.
Heart failure reviews 2006;11(2):135-9.
2006: Barry Greenberg; Faiez Zannad; Bertram Pitt
Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarction.
The American journal of cardiology 2006;97(10A):34F-40F.
2006: Bertram Pitt; Mihai Gheorghiade; Faiez Zannad; Jeffrey L Anderson; Dirk J van Veldhuisen; Alexander Parkhomenko; Ramon Corbalan; Eric Q Klug; Robin Mukherjee; Henry Solomon
Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction
European journal of heart failure 2006;8(3):295-301.

2006: Steven M Haffner; Luis M Ruilope; Björn Dahlöf; Eric Abadie; Stuart Kupfer; Faiez Zannad
Metabolic syndrome, new onset diabetes, and new end points in cardiovascular trials.
Journal of cardiovascular pharmacology 2006;47(3):469-75.
2006: francois alla; Anna Kearney-Schwartz; Anca Radauceanu; Sylvie Das Dores; Brigitte Dousset; Faiez Zannad
Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes.
European journal of heart failure 2006;8(2):147-53.
2006: Fatiha Maskali; Philippe R Franken; Sylvain Poussier; Nguyen Tran; Christian Vanhove; Henri Boutley; Hervé Le Gall; Gilles Karcher; Faiez Zannad; Patrick Lacolley; Pierre-Yves Marie
Initial infarct size predicts subsequent cardiac remodeling in the rat infarct model: an in vivo serial pinhole gated SPECT study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):337-44.
2005: Carole Seguin-Devaux; Didier Hanriot; Michèle Dailloux; Véronique Latger-Cannard; Faiez Zannad; Paul-Michel Mertes; Dan Longrois; Yvan Devaux
Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression.
Molecular and cellular endocrinology 2005;245(1-2):67-76.
2005: Mihai Gheorghiade; Faiez Zannad; George Sopko; Liviu Klein; Ileana L Piña; Marvin A Konstam; Barrie Massie; Edmond Roland; Shari Targum; Sean P Collins; Gerasimos Filippatos; Luigi Tavazzi
Acute heart failure syndromes: current state and framework for future research.
Circulation 2005;112(25):3958-68.
2005: ATHANASE BENETOS; Jeffrey P Gardner; Masayuki Kimura; carlos labat; Rosine Nzietchueng; Brigitte Dousset; Faiez Zannad; Patrick Lacolley; Abraham Aviv
Aldosterone and telomere length in white blood cells.
The journals of gerontology. Series A, Biological sciences and medical sciences 2005;60(12):1593-6.
2005: Fatiha Maskali; Adey Ayalew; Pierre-Yves Marie; Patrick Menu; Laurent Antunes; Paul-Michel Mertes; Faiez Zannad; Jean-Marc Gravier; Gilles Karcher; Alain Bertrand
Changes in first-pass interstitial kinetics of DTPA in myocardium submitted to low-flow ischemia.
Investigative radiology 2005;40(12):766-72.
2005: Harvey D White; Philip E G Aylward; Zhen Huang; Anthony J Dalby; W Douglas Weaver; Ståle Barvik; José Antonio Marin-Neto; Jan Murin; Rolf O Nordlander; Wiek H van Gilst; Faiez Zannad; john mcmurray; Robert M Califf; Marc A Pfeffer
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation 2005;112(22):3391-9.
2005: Camille Ducki; Audrey Rose; Anca Radauceanu; Faiez Zannad
[Proposal of a tool for providing patients with the main results of clinical research studies].
Thérapie 2005;60(6):545-51.
2005: Laura Zanetti; Anca Radauceanu; Renaud Fay; Mélanie Essevaz-Roulet; Nathalie Lefèvre; Faiez Zannad
[Performance evaluation of a tool for institutional protocol quality assurance].
Thérapie 2005;60(6):527-37.
2005: Willem J Remme; john mcmurray; Bernhard Rauch; Faiez Zannad; Karen Keukelaar; Alain Cohen-Solal; Jose Lopez-Sendon; F D Richard Hobbs; Diederick Grobbee; Alessandro Boccanelli; Charles Cline; Cezar Macarie; Rainer Dietz; Witold Ruzyllo
Public awareness of heart failure in Europe: first results from SHAPE.
European heart journal 2005;26(22):2413-21.
2005: Didier Quilliot; francois alla; Philip Böhme; Jean-François Bruntz; M Hammadi; Brigitte Dousset; Olivier Ziegler; Faiez Zannad
Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance.
International journal of obesity (2005) 2005;29(11):1321-8.
2005: Bertram Pitt; Harvey White; Jose Nicolau; Felipe Martinez; Mihai Gheorghiade; Michael Aschermann; Dirk J van Veldhuisen; Faiez Zannad; Henry Krum; Robin Mukherjee; John Vincent
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
Journal of the American College of Cardiology 2005;46(3):425-31.
2005: Didier Quilliot; Faiez Zannad; Olivier Ziegler
Impaired response of cardiac autonomic nervous system to glucose load in severe obesity.
Metabolism: clinical and experimental 2005;54(7):966-74.
2005: Pascale Dewachter; Jouan Hureaux Valerie; Patricia Franck; Patrick Menu; Nicole de Talancé; Faiez Zannad; Marie-Claire Laxenaire; Dan Longrois; Paul-Michel Mertes
Anaphylactic shock: a form of distributive shock without inhibition of oxygen consumption.
Anesthesiology 2005;103(1):40-9.
2005: Bengt Fellström; Faiez Zannad; Roland Schmieder; Hallvard Holdaas; Alan Jardine; Helen Rose; Wim Wilpshaar
Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study.
Current controlled trials in cardiovascular medicine 2005;6(1):9.
2005: Mihai Gheorghiade; Cesare Orlandi; John C Burnett; David L DeMets; Liliana Grinfeld; Aldo Maggioni; Karl Swedberg; James E Udelson; Faiez Zannad; Christopher Zimmer; Marvin A Konstam
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST).
Journal of cardiac failure 2005;11(4):260-9.
2005: Fatiha Maskali; Sylvain Poussier; Pierre-Yves Marie; Nguyen Tran; Laurent Antunes; Pierre Olivier; François Plenat; Serge Maîtrejean; Faiez Zannad; Gilles Karcher
High-resolution simultaneous imaging of SPECT, PET, and MRI tracers on histologic sections of myocardial infarction.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2005;12(2):229-30.
2005: Luis M Ruilope; Enrico Agabiti Rosei; George L Bakris; Giuseppe Mancia; Neil R Poulter; Stefano Taddei; Thomas Unger; Massimo Volpe; Bernard Waeber; Faiez Zannad
Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.
Blood pressure 2005;14(4):196-209.
2005: Faiez Zannad; Anca Radauceanu
Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure.
Heart failure reviews 2005;10(1):71-8.
2004: Jean-Jacques Mourad; Bernard Waeber; Faiez Zannad; Maurice Laville; Gérard Duru; Michel Andréjak
Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.
Journal of hypertension 2004;22(12):2379-86.
2004: Anca Radauceanu; Jean-Marc Boivin; Corine Bernaud; Renaud Fay; Faiez Zannad
Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
Fundamental & clinical pharmacology 2004;18(4):483-91.
2004: Marie Fouchard; Faiez Zannad
The results of major clinical trials: critical assessment, the circulation of information and media coverage.
Thérapie 2004;59(3):317-28.
2004: Adey Ayalew; Fatiha Maskali; Sandra Audonnet; Pierre-Yves Marie; Patrick Menu; Paul-Michel Mertes; Pierre Olivier; Patricia Franck; Faiez Zannad; Gilles Karcher; Alain Bertrand
Low-flow ischaemia has no deleterious effect on the steady-state kinetics of 201Tl and 99mTc sestamibi within myocardial tissue.
Nuclear medicine communications 2004;25(5):475-8.
2004: Douglas L Mann; john mcmurray; Milton Packer; Karl Swedberg; Jeffrey S Borer; Wilson S Colucci; Jacques Djian; Helmut Drexler; Arthur M Feldman; Lars Kober; Henry Krum; Peter Liu; Markku Nieminen; Luigi Tavazzi; Dirk Jan van Veldhuisen; Anders Waldenstrom; Marshelle Warren; Arne Westheim; Faiez Zannad; Thomas Fleming
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).
Circulation 2004;109(13):1594-602.
2004: Willem J Remme; Alessandro Boccanelli; Charles Cline; Alain Cohen-Solal; Rainer Dietz; Richard F D Hobbs; Karen Keukelaar; Jose Lopez Sendon; Cezar Macarie; John McMurray; Bernhard Rauch; Witold Ruzyllo; Faiez Zannad
Increasing awareness and perception of heart failure in Europe and improving care--rationale and design of the SHAPE Study.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(2):153-9.
2004: Pierre-Yves Marie; Paul-Michel Mertes; Nathalie Hassan-Sebbag; Nicole de Talence; Karim Djaballah; Wassila Djaballah; Johan Friberg; Pierre Olivier; Gilles Karcher; Faiez Zannad; Alain Bertrand
Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by beta-blockers.
Journal of the American College of Cardiology 2004;43(3):353-9.
2004: Tabassome Simon; Pierre Boutouyrie; anne Gompel; Sophie Christin-Maitre; Stéphane Laurent; Christian Thuillez; Faiez Zannad; Corine Bernaud; Patrice Jaillon
Rationale, design and methods of the CASHMERE study.
Fundamental & clinical pharmacology 2004;18(1):131-8.
2003: Bertram Pitt; Nathaniel Reichek; Roland Willenbrock; Faiez Zannad; Robert A Phillips; Barbara Roniker; Jay H Kleiman; Scott Krause; Daniel Burns; Gordon H Williams
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Circulation 2003;108(15):1831-8.
2003: Nathalie Thilly; Serge Briançon; Yves Juillière; Edith Dufay; Faiez Zannad
Improving ACE inhibitor use in patients hospitalized with systolic heart failure: a cluster randomized controlled trial of clinical practice guideline development and use.
Journal of evaluation in clinical practice 2003;9(3):373-82.
2003: Michel Andréjak; Faiez Zannad; Maurice Laville; Gérard Duru; Jean-Jacques Mourad; Bernard Waeber
[Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment].
Thérapie 2003;58(4):351-2.
2003: Nathalie Thilly; Faiez Zannad; Edith Dufay; Yves Juillière; Serge Briançon
[Angiotensin-converting enzyme inhibitors in congestive heart failure: clinical practice guidelines].
Thérapie 2003;58(4):341-9.
2003: Pierre-Yves Marie; Christelle Mercennier; Nicolas Danchin; Karim Djaballah; Alain Grentzinger; Faiez Zannad; Pierre Olivier; Wassila Djaballah; Gilles Karcher; jean-marc virion; Alain Bertrand
Residual exercise SPECT ischemia on treatment is a main determinant of outcome in patients with coronary artery disease treated medically at long-term with beta-blockers.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2003;10(4):361-8.
2003: Yannick Plétan; Faiez Zannad; Patrice Jaillon
Public information about clinical trials and research.
Thérapie 2003;58(3):185-208.
2003: Faiez Zannad; Anca Radauceanu; Gianfranco Parati
Trough-to-peak ratio, smoothness index and morning-to-evening ratio: why, which and when?
Journal of hypertension 2003;21(5):851-4.
2003: Bertram Pitt; Willem J Remme; Faiez Zannad; James D Neaton; Felipe Martinez; Barbara Roniker; Richard Bittman; Steve Hurley; Jay H Kleiman; Marjorie Gatlin
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
The New England journal of medicine 2003;348(14):1309-21.
2003: Faiez Zannad; ATHANASE BENETOS
Genetics of intima-media thickness.
Current opinion in lipidology 2003;14(2):191-200.
2002: Anca Radauceanu; jean-marc virion; Jean-Marc Boivin; Faiez Zannad
Time-effect profile of antihypertensive agents assessed with trough/peak ratio, smoothness index and dose omission: an ambulatory blood pressure monitoring study with trandolapril vs. quinapril.
Fundamental & clinical pharmacology 2002;16(6):545-54.
2002: Faiez Zannad; Michèle Kessler; Jean-Pierre Grünfeld; Christian Thuilliez
FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics.
Fundamental & clinical pharmacology 2002;16(5):353-60.
2002: Faiez Zannad; Bertrand Gille; Alain Grentzinger; Jean-François Bruntz; Mokrane Hammadi; Jean-Marc Boivin; Corinne Hanotin; Bruno Igau; Pierre Drouin
Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction.
American heart journal 2002;144(3):508-15.
2002: Carole Seguin-Devaux; Yvan Devaux; Véronique Latger-Cannard; Sandrine A Grosjean; Cécile Rochette-Egly; Faiez Zannad; Claude Meistelman; Paul-Michel Mertes; Dan Longrois
Enhancement of the inducible NO synthase activation by retinoic acid is mimicked by RARalpha agonist in vivo.
American journal of physiology. Endocrinology and metabolism 2002;283(3):E525-35.
2002: francois alla; Serge Briançon; Francis Guillemin; Yves Juillière; Paul-Michel Mertès; Jean-Pierre Villemot; Faiez Zannad
Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study.
European journal of heart failure 2002;4(3):337-43.
2001: Faiez Zannad; Brigitte Dousset; francois alla
Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship.
Hypertension 2001;38(5):1227-32.
2001: Carole Seguin; Yvan Devaux; Sandrine A Grosjean; EM Siaghy; P Mairose; Faiez Zannad; Nicole de Talancé; Dan Ungureanu-Longrois; Paul-Michel Mertes
Evidence of functional myocardial ischemia associated with myocardial dysfunction in brain-dead pigs.
Circulation 2001;104(12 Suppl 1):I197-201.
2001: Bruno Guerci; Philip Böhme; Anna Kearney-Schwartz; Faiez Zannad; Pierre Drouin
Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
Diabetes & metabolism 2001;27(4 Pt 1):436-47.
2001: Bruno Guerci; Anna Kearney-Schwartz; Philip Böhme; Faiez Zannad; Pierre Drouin
Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function.
Diabetes & metabolism 2001;27(4 Pt 1):425-34.
2001: Sandrine A Grosjean; Yvan Devaux; Carole Seguin; Claude Meistelman; Faiez Zannad; Paul-Michel Mertes; Ralph A Kelly; Dan Ungureanu-Longrois
Retinoic acid attenuates inducible nitric oxide synthase (NOS2) activation in cultured rat cardiac myocytes and microvascular endothelial cells.
Journal of molecular and cellular cardiology 2001;33(5):933-45.
2001: Didier Quilliot; L Fluckiger; Faiez Zannad; Pierre Drouin; Olivier Ziegler
Impaired autonomic control of heart rate and blood pressure in obesity: role of age and of insulin-resistance.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2001;11(2):79-86.
2001: Bertram Pitt; G Williams; Willem J Remme; Felipe Martinez; Jose Lopez-Sendon; Faiez Zannad; James D Neaton; Barbara Roniker; S Hurley; D Burns; R Bittman; Jay H Kleiman
The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2001;15(1):79-87.
2001: Francis Fagnani; L Buteau; jean-marc virion; Serge Briançon; Faiez Zannad
[Management, cost and mortality of a cohort of patients with advanced heart failure (the EPICAL study)].
Thérapie 2001;56(1):5-10.
2000: Faiez Zannad; francois alla; Brigitte Dousset; A Perez; Bertram Pitt
Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.
Circulation 2000;102(22):2700-6.
2000: Yvan Devaux; Sandrine A Grosjean; Carole Seguin; C David; B Dousset; Faiez Zannad; Claude Meistelman; Nicole de Talancé; Paul-Michel Mertes; Dan Ungureanu-Longrois
Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo.
American journal of physiology. Endocrinology and metabolism 2000;279(5):E1045-53.
2000: EM Siaghy; Yvan Devaux; Henri Schroeder; N Sfaksi; Dan Ungureanu-Longrois; Faiez Zannad; Jean-Pierre Villemot; Pierre Nabet; Paul-Michel Mertes
High-performance liquid chromatographic analysis of muscular interstitial arginine and norepinephrine kinetics. A microdialysis study in rats.
Journal of chromatography. B, Biomedical sciences and applications 2000;745(2):279-86.
2000: M Echemann; Faiez Zannad; S Briançon; Y Juillière; P M Mertès; jean-marc virion; Jean-Pierre Villemot
Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study.
American heart journal 2000;139(4):624-31.
2000: EM Siaghy; Yvan Devaux; N Sfaksi; Jean-Pierre Carteaux; Dan Ungureanu-Longrois; Faiez Zannad; Jean-Pierre Villemot; C Burlet; Paul-Michel Mertes
Consequences of inspired oxygen fraction manipulation on myocardial oxygen pressure, adenosine and lactate concentrations: a combined myocardial microdialysis and sensitive oxygen electrode study in pigs.
Journal of molecular and cellular cardiology 2000;32(3):493-504.
2000: Carole Seguin; Yvan Devaux; Nathalie Aubert; EM Siaghy; Faiez Zannad; C Burlet; Dan Ungureanu-Longrois; Paul-Michel Mertes
Consequences of labetalol administration on myocardial beta adrenergic receptors in the brain dead pig.
Annals of transplantation : quarterly of the Polish Transplantation Society 2000;5(4):54-60.
2000: Faiez Zannad
The potential advantages of a modern antihypertensive therapy in the elderly.
Journal of cardiovascular pharmacology 2000;35(3 Suppl 1):S19-23.
1999: Bertram Pitt; Faiez Zannad; Willem J Remme; robert cody; A Castaigne; A Perez; J Palensky; Janet Wittes
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
The New England journal of medicine 1999;341(10):709-17.
1999: Pierre-Yves Marie; Nicolas Danchin; F Branly; Michael Angioï; Alain Grentzinger; jean-marc virion; B Brouant; Pierre Olivier; Gilles Karcher; Yves Juillière; Faiez Zannad; Alain Bertrand
Effects of medical therapy on outcome assessment using exercise thallium-201 single photon emission computed tomography imaging: evidence of a protective effect of beta-blocking antianginal medications.
Journal of the American College of Cardiology 1999;34(1):113-21.
1999: L Fluckiger; J M Boivin; Didier Quilliot; C Jeandel; Faiez Zannad
Differential effects of aging on heart rate variability and blood pressure variability.
The journals of gerontology. Series A, Biological sciences and medical sciences 1999;54(5):B219-24.
1999: Faiez Zannad; S Briancon; Y Juilliere; Paul-Michel Mertes; Jean-Pierre Villemot; francois alla; jean-marc virion
Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine.
Journal of the American College of Cardiology 1999;33(3):734-42.
1999: Faiez Zannad; C M Bernaud; R Fay
Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension. General Physicians Investigators' Group.
Journal of hypertension 1999;17(1):137-46.
1998: Y Khder; S Briançon; R Petermann; Didier Quilliot; J F Stoltz; Pierre Drouin; Faiez Zannad
Shear stress abnormalities contribute to endothelial dysfunction in hypertension but not in type II diabetes.
Journal of hypertension 1998;16(11):1619-25.
1998: Faiez Zannad; Z Chati; M Guest; F Plat
Differential effects of fosinopril and enalapril in patients with mild to moderate chronic heart failure. Fosinopril in Heart Failure Study Investigators.
American heart journal 1998;136(4 Pt 1):672-80.
1998: Z Chati; Jean-François Bruntz; G Ethévenot; Etienne Aliot; Faiez Zannad
Abnormal transoesophageal Doppler coronary flow reserve in patients with dilated cardiomyopathy: relationship to exercise capacity.
Clinical science (London, England : 1979) 1998;94(5):485-92.
1998: Y Khder; L Bray des Boscs; R el Ghawi; B Meilhac; F Montestruc; J F Stoltz; Faiez Zannad
Calcium antagonists and thiazide diuretics have opposite effects on blood rheology and radial artery compliance in arterial hypertension: a randomized double-blind study.
Fundamental & clinical pharmacology 1998;12(4):457-62.
1998: C Michel; Z Chati; Paul-Michel Mertes; J M Escanye; Faiez Zannad
Physical activity, skeletal muscle beta-adrenoceptor changes and oxidative metabolism in experimental chronic heart failure.
Fundamental & clinical pharmacology 1998;12(3):263-9.
1997: Y Khder; L Bray-Desboscs; E Aliot; Faiez Zannad
Effects of blood pressure control on radial artery diameter and compliance in hypertensive patients.
American journal of hypertension 1997;10(3):269-74.
1996: Z Chati; P M Mertès; Etienne Aliot; Faiez Zannad
Plasma levels of atrial natriuretic peptide and of other vasoconstricting hormones in patients with chronic heart failure: relationship to exercise capacity.
International journal of cardiology 1996;57(2):135-42.
1996: Z Chati; C Michel; J M Escanye; Paul-Michel Mertes; C Ribuot; Daniel Canet; Faiez Zannad
Skeletal muscle beta-adrenoreceptors and phosphate metabolism abnormalities in heart failure in rats.
The American journal of physiology 1996;271(5 Pt 2):H1739-45.
1996: Y Khder; R el Ghawi; L B Boscs; E Aliot; Faiez Zannad
Investigations of the peripheral vascular mechanisms implicated in congestive heart failure by the non-invasive evaluation of radial artery compliance and reactivity.
International journal of cardiology 1996;56(2):149-58.
1996: Faiez Zannad; A Matzinger; J Larché
Trough/peak ratios of once daily angiotensin converting enzyme inhibitors and calcium antagonists.
American journal of hypertension 1996;9(7):633-43.
1996: Z Chati; Faiez Zannad; C Jeandel; B Lherbier; J Robert; Etienne Aliot
Physical deconditioning may be a mechanism for the skeletal muscle energy phosphate metabolism abnormalities in chronic heart failure.
American heart journal 1996;131(3):560-6.
1994: Z Chati; Faiez Zannad; C Michel; B Lherbier; Paul-Michel Mertes; J M Escanye; C Ribout; J Robert; Jean-Pierre Villemot; Etienne Aliot
Skeletal muscle phosphate metabolism abnormalities in volume-overload experimental heart failure.
The American journal of physiology 1994;267(6 Pt 2):H2186-92.
1994: Z Chati; Faiez Zannad; B Robin-Lherbier; J M Escanye; C Jeandel; J Robert; Etienne Aliot
Contribution of specific skeletal muscle metabolic abnormalities to limitation of exercise capacity in patients with chronic heart failure: a phosphorus 31 nuclear magnetic resonance study.
American heart journal 1994;128(4):781-92.
1994: Z Chati; Faiez Zannad
[Metabolic, morpho-histologic and biochemical changes in skeletal muscles in chronic cardiac failure].
Archives des maladies du coeur et des vaisseaux 1994;87 Spec No 2():17-26.
1993: Faiez Zannad; L Bray-Desboscs; R el Ghawi; M Donner; E Thibout; J F Stoltz
Effects of lisinopril and hydrochlorothiazide on platelet function and blood rheology in essential hypertension: a randomly allocated double-blind study.
Journal of hypertension 1993;11(5):559-64.
1992: Faiez Zannad; S A van den Broek; M Bory
Comparison of treatment with lisinopril versus enalapril for congestive heart failure.
The American journal of cardiology 1992;70(10):78C-83C.
1990: Pierre-Yves Marie; J M Escanye; F Brunotte; B Robin; P Walker; Faiez Zannad; J Robert; J M Gilgenkrantz
Skeletal muscle metabolism in the leg during exercise in patients with congestive heart failure.
Clinical science (London, England : 1979) 1990;78(5):515-9.
1989: J Anconina; J F Bruntz; G Audibert; A Hueber; Faiez Zannad; J P Villemot; J M Gilgenkrantz
[Hemolytic anemia and cardiac heterografts. Apropos of 2 cases].
Archives des maladies du coeur et des vaisseaux 1989;82(2):237-9.
1988: Faiez Zannad; P Voisin; F Brunotte; J F Bruntz; J F Stoltz; J M Gilgenkrantz
Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy.
Journal of hypertension 1988;6(4):293-7.
1985: Faiez Zannad; C Medeiros; P Voisin; J F Bruntz; F Stoltz; J M Gilgenkrantz
[Blood hyperviscosity syndrome in essential arterial hypertension. Characterization and clinical effects].
Archives des maladies du coeur et des vaisseaux 1985;78(11):1706-9.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.